May 26, 2026
Engineering better cancer fighters: In conversation with Justin Milner
UNC Lineberger's Justin Milner, PhD, has emerged in recent years as a young scientist to watch in the field of cancer immunology.
Tag: Home News
May 22, 2026
Brewer receives American Cancer Society’s Volunteer Leadership Award
The ACS has honored Noel Brewer, PhD, with its Volunteer Leadership Award, which recognizes those who have taken on major volunteer leadership roles for ACS or have given many years of exceptional service across the organization.
May 20, 2026
UNC researchers develop faster, low-cost method to diagnose common pediatric cancer
Jeremy R. Wang, PhD, and colleagues have created a new way for oncologists to more sensitively detect genetic mutations in B-cell acute lymphoblastic leukemia (B-ALL), the most common type of pediatric cancer.
May 15, 2026
UNC study reveals promising new therapy for non-Hodgkin lymphoma
The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma.
May 14, 2026
UNC researchers create more effective, less toxic immunotherapy to combat blood cancer
Gianpietro Dotti, MD, Paul Armistead, MD, PhD, and colleagues have created a new cellular immunotherapy that targets acute myeloid leukemia (AML) cells without impacting normal blood production, which is one of the major challenges associated with AML treatment.
May 14, 2026
Rewiring T cell signals in cancer
H. Kay Chung, PhD, received a Chan Zuckerberg Biohub Synthetic Biology Award to rewire T cell signaling in cancer, enabling T cells to reinterpret tumor-derived cues and sustain anti-tumor activity.
May 13, 2026
What is a glioblastoma?
Glioblastomas are the most common malignant brain tumor. Learn more about glioblastoma risk factors, symptoms, treatments and clinical trials.
May 7, 2026
Der, Yeh provide scientific context for recent progress in RAS therapeutics for pancreatic cancer
Channing J. Der, PhD, and Jen Jen Yeh, MD, published an editorial contextualizing a landmark clinical study evaluating daraxonrasib, a first-in-class drug targeting KRAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC).
May 7, 2026
Perou named Honorary Doctor by Karolinska Institutet
UNC Lineberger's Charles Perou, PhD, was awarded the title of Honorary Doctor by Karolinska Institutet in Sweden in recognition of his groundbreaking contributions to breast cancer research.
May 7, 2026
Updated alcohol warning labels may prompt people to cut back
New labels on alcoholic beverages warning of specific disease risks, including cancer and liver disease, could better motivate reduced drinking, according to a new study.